Latest Prescription Drugs news
FDA Approves First Topical Treatment for Vitiligo
posted July 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
WHO Guideline Advises Against Fluvoxamine, Colchicine for COVID-19
posted July 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Diabetic Macular Edema Outcomes Compared for Aflibercept, Bevacizumab
posted July 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Survival Advantage Seen for A+ADV in Advanced Hodgkin Lymphoma
posted July 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
Frequent Cannabis Use Linked to Epilepsy Severity Monthly Specialist Briefings
Stay Connected
